Nothing Special   »   [go: up one dir, main page]

Tomasini et al., 2016 - Google Patents

EGFR and KRAS mutations predict the incidence and outcome of brain metastases in non-small cell lung cancer

Tomasini et al., 2016

View HTML
Document ID
1399772460611430667
Author
Tomasini P
Serdjebi C
Khobta N
Metellus P
Ouafik L
Nanni I
Greillier L
Loundou A
Fina F
Mascaux C
Barlesi F
Publication year
Publication venue
International journal of molecular sciences

External Links

Snippet

Background: Lung cancer is the leading cause of brain metastases (BM). The identification of driver oncogenes and matched targeted therapies has improved outcome in non-small cell lung cancer (NSCLC) patients; however, a better understanding of BM molecular …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01—Social networking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management

Similar Documents

Publication Publication Date Title
Tomasini et al. EGFR and KRAS mutations predict the incidence and outcome of brain metastases in non-small cell lung cancer
Passaro et al. Genomic characterization of concurrent alterations in Non-Small Cell Lung Cancer (NSCLC) harboring actionable mutations
Fan et al. ADAM9 expression is associate with glioma tumor grade and histological type, and acts as a prognostic factor in lower-grade gliomas
Rau et al. Discordance of mutation statuses of epidermal growth factor receptor and K-ras between primary adenocarcinoma of lung and brain metastasis
Langer et al. Expression analysis of autophagy related markers LC3B, p62 and HMGB1 indicate an autophagy-independent negative prognostic impact of high p62 expression in pulmonary squamous cell carcinomas
Saini et al. Liquid biopsy in gastrointestinal cancers
Wu et al. Nuclear-biased DUSP6 expression is associated with cancer spreading including brain metastasis in triple-negative breast cancer
Jiang et al. The role of amino acid metabolism of tumor associated macrophages in the development of colorectal cancer
Muster et al. Contrasts in glioblastoma—venous thromboembolism versus bleeding risk
Inomata et al. Association of tumor PD-L1 expression with the T790M mutation and progression-free survival in patients with EGFR-mutant non-small cell lung cancer receiving EGFR-TKI therapy
Jung et al. Validating the ACOSOG Z0011 trial result: a population-based study using the SEER database
Kawamoto et al. Prostaglandin E-major urinary metabolite (PGE-MUM) as a tumor marker for lung adenocarcinoma
Silva et al. Baseline and kinetic circulating tumor cell counts are prognostic factors in a prospective study of metastatic colorectal cancer
Olsen et al. Real-world clinical outcomes after genomic profiling of circulating tumor DNA in patients with previously treated advanced non-small cell lung cancer
Proescholdt et al. Brain metastases in elderly patients—the role of surgery in the context of systemic treatment
Winter et al. Alpha smooth muscle actin (αSMA) immunohistochemistry use in the differentiation of pancreatic cancer from chronic pancreatitis
Kumaki et al. Comprehensive genomic profiling of circulating cell-free DNA distinguishes focal MET amplification from aneuploidy in diverse advanced cancers
Ottaiano et al. KRAS p. G12C mutation in metastatic colorectal cancer: prognostic implications and advancements in targeted therapies
Wu et al. Comparison of different tyrosine kinase inhibitors for treatment of poor performance status patients with EGFR-mutated lung adenocarcinoma
Gauvin et al. Survival impact of aggressive treatment and PD-L1 expression in oligometastatic NSCLC
Spirina et al. Molecular protein and expression profile in the primary tumors of clear cell renal carcinoma and metastases
Yang et al. Significance of phosphorylated epidermal growth factor receptor and its signal transducers in human soft tissue sarcoma
Ito et al. Narrow-margin excision for invasive acral melanoma: is it acceptable?
Levy et al. Histologic grade is predictive of incidence of epidermal growth factor receptor mutations in metastatic lung adenocarcinoma
Esposito Abate et al. Liquid biopsy testing can improve selection of advanced non-small-cell lung cancer patients to rechallenge with gefitinib